HEALTH NEWS
FDA: J&J halted antibiotic study over poor results
Posted: Jan 6, 2012 9:29 AM by Associated Press (JM)
NEW BRUNSWICK, N.J. (AP) - The Food and Drug Administration says Johnson and Johnson has halted a study of an additional use for its antibiotic Doribax, in patients who developed pneumonia while on a breathing machine.
The FDA says more patients taking Doribax died and fewer were cured than in the comparison group getting other drugs.
Johnson & Johnson and its Janssen Pharmaceuticals unit, which makes the injected drug, did not disclose the decision when the study was halted last May.
J&J said Friday that the study was ended on the recommendation of an independent monitoring committee. Doribax remains on the market for two approved uses, infections in the abdomen and urinary tract infections.
Johnson & Johnson shares were down 51 cents at $64.89 in midday trading.
PLEASE HELP US MODERATE COMMENTS
Offensive or inappropriate comments are subject to removal. To report a comment, please e-mail us at feedback@ksby.com, and include the name of the story and information on the comment.
Thank you! KSBY.com
KSBY.com is social!
Most Popular
HotSpot
California Mid-State Fair
The California Mid-State Fair is just around the corner. See what's coming up!
Calendar
Wondering what to do this weekend? Check out our calendar of events across the Central Coast.
CA Lottery
Did you win? Check your numbers here. KSBY, the official CA Lottery station for the Central Coast.
KSBY.COM VIDEOS
Comments